We have an excellent record of industrial engagement. Three companies have embedded staff in the RCaH and there are more than 50 industrial collaborations within the groups.
The Continuous Manufacturing and Crystallisation Hub has 22 industrial partners (including GlaxoSmithKline, AstraZeneca and Bayer), the Catalysis Hub has 14 (Johnson Matthey being the main one) and the Powder Manufacturing Hub has 17 (including Rolls-Royce, GKN and Element Six). Together, we have funding for more than 12 PhD students. Industrial CASE studentships are working on projects from imaging techniques to additive manufacturing, together with co-funding of researchers on projects from aerospace to making better ice cream.
In life sciences, RCaH is an influential member of the HealthTec Cluster, a partnership of the local industry, STFC, the Oxford Local Enterprise Partnership, the Rosalind Franklin Institute, MRC-Harwell, the European Space Agency and Public Health England.
RCaH has also been integral in developing a campus-wide EnergyTec Cluster to bring energy companies into the science park (there are already about 20 energy companies at Harwell), with a goal of acting as a Hub for developing the research strengths in the Large Facilities to support them.
Harwell and Oxford Science Park users are able to access our high-quality equipment at a cost. This can either be through using the equipment by a member of your team (after full training given) or by our trained experts. RCaH has tremendous expertise both within our core team and within the resident groups. RCaH also can add value to users of the Central Facilities by offering space/equipment for the preparation of their experiments. For more information on access, please contact the Operations Manager.